Mintz advised Foster Corporation, a differentiated compounder of biomedical polymers used in the high-growth healthcare and medical device industry, on an acquisition by GEON® Performance Solutions, a global leader in the formulation, development, and manufacture of performance polymer solutions.
The addition of Foster Corporation to GEON’s portfolio will enhance GEON’s position in the high-value medical market, with Foster serving as the face of its medical end market.
More information can be found here.
The Mintz team that advised on the acquisition included Private Equity Co-chairs Gregory Fine and Kurt Steinkrauss, Member Katya Daniel, and Associate Zachary Liebnick.
Supporting Professionals
